The Master of Science in Biotechnology and Pharmaceutical Engineering at Carnegie Mellon University prepares you to design and improve biomanufacturing processes and drug development workflows. The programme combines biological sciences with chemical engineering to support careers in healthcare innovation, research, and industry.
The Master of Science in Biotechnology and Pharmaceutical Engineering at Carnegie Mellon University equips students with the skills necessary to design and enhance biomanufacturing processes and drug development workflows. This interdisciplinary program merges biological sciences with chemical engineering, paving the way for exciting careers in healthcare innovation, research, and industry.
Programme structure
The program is designed to be completed in 24 months of full-time study, incorporating essential engineering and life-science coursework alongside practical, industry-relevant experiences.
Core coursework includes:
Applied learning and capstone experience
Students engage in a comprehensive research or project component that aligns with the practices of biotechnology and pharmaceutical engineering. This may involve original research, a supervised project, or a capstone deliverable, depending on the chosen track and faculty resources.
Additional topics within the curriculum may cover:
While there are no specific GRE or GMAT score requirements for this program, prospective students should be aware that no minimum GPA threshold has been established. Applicants are encouraged to review all necessary application materials prior to submission.
Graduates of the Master of Science in Biotechnology and Pharmaceutical Engineering program are well-prepared to enter a variety of fields within healthcare innovation and pharmaceutical development. Career opportunities may include roles in biomanufacturing, regulatory affairs, quality assurance, and research and development, among others.
Shortlist scholarships and plan your application — free guidance from our advisors.